XML 34 R24.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 3 - Summary of Significant Accounting Policies (Details Textual) - USD ($)
3 Months Ended
Feb. 12, 2016
Mar. 31, 2016
Mar. 31, 2015
Private Placement [Member] | Series B Preferred Stock [Member] | Placement Agent Warrants [Member]      
Class of Warrant or Right, Issued 127,346    
Private Placement [Member] | Series B Preferred Stock [Member] | Strategic Bio Partners [Member] | Debt Settlement [Member]      
Class of Warrant or Right, Issued 295,945    
Options and Warrants [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   5,217,800 4,851,111
Convertible Preferred Shares [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   10,598,506 4,600,000,000
Goodwill, Fair Value Disclosure $ 0    
Fair Value Assumptions, Expected Dividend Rate   0.00%  
Derivative, Gain (Loss) on Derivative, Net   $ (1,507)